A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells

New artificial fluoro-cofactor of hydride transfer with novel fluorescence assay for redox biocatalysis

(2016) Lei Zhang et al.   CHEMICAL COMMUNICATIONS

Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

(2016) Yuhui Yang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Development of Azo-Based Fluorescent Probes to Detect Different Levels of Hypoxia

(2013) Wen Piao et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death

(2013) Gang Cheng et al.   BMC CANCER

The first latent green fluorophores for the detection of azoreductase activity in bacterial cultures

(2013) Arnaud Chevalier et al.   CHEMICAL COMMUNICATIONS

Targeting cancer cell mitochondria as a therapeutic approach

(2012) Shijun Wen et al.   Future Medicinal Chemistry

Nitro seco Analogues of the Duocarmycins Containing Sulfonate Leaving Groups as Hypoxia-Activated Prodrugs for Cancer Therapy

(2012) Ralph J. Stevenson et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Photoisomerization in different classes of azobenzene

(2011) H. M. Dhammika Bandara et al.   CHEMICAL SOCIETY REVIEWS

Hypoxia Activated Prodrugs of a 9-Aza-anthrapyrazole Derivative That Has Promising Anticancer Activity

(2011) Mohammad H. El-Dakdouki et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hypoxia-Sensitive Fluorescent Probes forin VivoReal-Time Fluorescence Imaging of Acute Ischemia

(2010) Kazuki Kiyose et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Hypoxia-Activated Prodrugs: Substituent Effects on the Properties of Nitroseco-1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) Prodrugs of DNA Minor Groove Alkylating Agents

(2009) Moana Tercel et al.   JOURNAL OF MEDICINAL CHEMISTRY